logo
  

Globus Medical Results Top Estimate, CFO Rick Baron Resigns; Stock Down 4%

Globus Medical Inc. (GMED), a musculoskeletal implant maker, Thursday reported third-quarter net earnings of $23 million or $0.24 per share compared with $20.3 million or $0.22 per share last year.

Revenues for the quarter were $117.8 million compared with $107 million in the prior year.

Analysts polled by Thomson Reuters estimated earnings of $0.21 per share on revenues of $113 million for the quarter. Analysts' estimates typically exclude special items.

The company announced the resignation of Rick Baron, senior vice president and chief financial officer. Baron, who is resigning to pursue other interests, will remain with the company to assist with the transition during the search for his replacement.

Dave Demski, the company's president and chief operating officer, will assume the role of CFO on an interim basis. Demski previously served as the company's CFO from 2003 until his promotion to COO in 2008.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
French drug major Sanofi reported Thursday weak profit in its first quarter, despite higher net sales. The company also maintained its fiscal 2024 outlook. Sanofi shares were gaining around 4 percent in Paris trading as well as in pre-market activity on the Nasdaq. While reporting financial results for the first quarter on Wednesday, medical devices company Boston Scientific Corp. (BSX) raised its adjusted earnings and net sales growth guidance for the full-year 2024. For fiscal 2024, the company now projects earnings in a range of $1.43 to $1.48 per share and... Shares of Roche Holding AG were losing around 3 percent in Switzerland after the drug major reported weak sales in its first quarter and confirmed fiscal 2024 outlook. Excluding COVID-19-related products, quarterly sales increasedy 7 percent. For fiscal 2024, Roche continues to expect an increase in group sales in the mid single digit range at constant exchange rates.

This week, we feature Nigeria’s combat with meningitis, Hostile takeover bid for Vanda Pharma, US opioid crisis, Sammy’s Milk’s safety concerns, and X4’s Mavorixafor’s fast-track status.

View More Videos
Follow RTT